Hudson Bay Capital Management
GSK icon

Hudson Bay Capital Management’s GSK GSK Stock Holding History

Hudson Bay Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-800,000
Closed -$43.5M – 1277
2022
Q2 		$43.5M Buy
+800,000
New +$44.2M 0.33% 62

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Hudson Bay Capital Management's GSK Position: Q4 2025 in Review

Hudson Bay Capital Management sold out of GSK (GSK) in Q4 2025, closing a stake of 101,429 shares — an estimated $4.38M sold.

Hudson Bay Capital Management first reported a position in GSK in Q3 2017 and held it in 10 quarters. The position peaked at $43.5M in Q2 2022. 996 funds tracked by Wall St. Rank hold GSK as of Q4 2025.

  • Hudson Bay Capital Management reported no remaining GSK position as of Q4 2025 after selling out during the quarter.
  • Hudson Bay Capital Management sold 101,429 GSK shares in Q4 2025, an estimated $4.38M.
  • Hudson Bay Capital Management first reported a position in GSK in Q3 2017 and held it in 10 quarters.
  • Hudson Bay Capital Management's GSK position peaked at $43.5M in Q2 2022.
  • 996 funds tracked by Wall St. Rank held GSK as of Q4 2025.

Based on Hudson Bay Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.